Private financing raises $26 million for Nanogen:
This article was originally published in Clinica
Executive Summary
Nanogen has netted $26 million in a private round of financing managed by brokers Cowen & Co. Nanogen's R&D is centred on its Automated Programmable Electronic Matrix (APEX) microchip technology. Based in San Diego, California, the company is working on products for infectious disease diagnosis and genetic screening among others.